Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

Kane Biotech logo
C$0.04 0.00 (0.00%)
As of 08/8/2025 03:28 PM Eastern

About Kane Biotech Stock (CVE:KNE)

Key Stats

Today's Range
C$0.04
C$0.04
50-Day Range
C$0.04
C$0.07
52-Week Range
C$0.04
C$0.16
Volume
161,000 shs
Average Volume
73,745 shs
Market Capitalization
C$5.76 million
P/E Ratio
1.00
Dividend Yield
3.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

KNE Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Kane Biotech to Present at Advanced Wound Care Summit USA
Kane Biotech to Present at Advanced Wound Care Summit USA
Kane Biotech Provides Further Corporate Update
See More Headlines

KNE Stock Analysis - Frequently Asked Questions

Kane Biotech's stock was trading at C$0.11 at the beginning of the year. Since then, KNE stock has decreased by 63.6% and is now trading at C$0.04.

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:KNE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.04
Trailing P/E Ratio
1.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$6.03 million
Net Margins
423.52%
Pretax Margin
N/A
Return on Equity
-94.49%
Return on Assets
-58.43%

Debt

Debt-to-Equity Ratio
-331.42
Current Ratio
0.80
Quick Ratio
0.39

Sales & Book Value

Annual Sales
C$1.42 million
Price / Sales
4.05
Cash Flow
C$0.00 per share
Price / Cash Flow
8.50
Book Value
C($0.01) per share
Price / Book
-7.77

Miscellaneous

Outstanding Shares
144,060,190
Free Float
N/A
Market Cap
C$5.76 million
Optionable
Not Optionable
Beta
0.52
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:KNE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners